Browsing by Author "Abenezer Admasu"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Food Security and Malnutrition among Children with Selected Chronic Illness on Follow up at St. Paul’s Hospital, Ethiopia: A Cross-Sectional Study.
    (Addis Ababa University, 2024-06) Abenezer Admasu; Abebe Haile (PhD)
    Children living with chronic disease are at risk for food insecurity but evidence about food insecurity status and its predictors is scarce in this group of population, particularly developing countries like Ethiopia. As a result, the objective of this study was to assess the food security of malnutrition among children with chronic disease on follow up at St. Paul Hospital Millenium Medical College. A Cross-sectional study was conducted from Jan 1 to June 1, 2024 G.C. Data were collected when the patients came for follow up from both the patient/ care taker and chart. Anthropometric data at the time of diagnosis and on follow up were taken from the chart and current anthropometries were measured as per the standard protocol. The collected data was analyzed using SPSS 27 and it was subjected to both descriptive and inferential statistics. Accordingly, 332 out of the 414 children with chronic diseases (80.2%) suffer from food insecurity in their respective household. But 319 (77.1%) of them were mild. Only 13 (3.1%) of them suffer from moderate food insecurity. Children with chronic disease who were severely stunted, severely underweight, and severely wasted accounted for 143 (34.5%), 95 (22.9%), and 45 (10.9%) of the participants, respectively. Overall, any kind of stunting, underweight, and wasting was found in 44.9%, 39.8%, and 18.4% of the cases, correspondingly. Though there was no variable significantly associated with food insecurity and malnutrition was higher in children with diabetes (86.5%) and RVI (81.5%). The levels of food insecurity, stunting, underweight, and wasting were higher in children with chronic diseases than the general child population. Therefore, health professionals should be trained to identify food insecurity and malnourishment in under-five children with chronic illnesses and should advise caretakers on nutrition.
  • No Thumbnail Available
    Item
    Outcome of Apnea Management With Aminophylline and Associated Factors Among Preterm Infants Admitted to Public Hospitals, Addis Ababa, Ethiopia, 2024: Retrospective Study
    (Addis Ababa University, 2024-09-18) Abenezer Admasu; Wudma Alemu; Yeshi Berhan
    Background: Prematurity (birth before 37 weeks of gestation) can lead to serious complications. One such complication is apnea (a temporary cessation of breathing) and this complication can be fatal. Management of apnea with Aminophylline among preterm babies has shown a promise by stimulating the respiratory center and improving respiratory function. But evidences on the outcome of aminophylline use for treatment of apnea in preterm babies is scanty in developing countries, like Ethiopia. Objective: This study aimed at assessing the outcome of aminophylline use for management of apnea and associated factors among preterm infants admitted to public hospitals, Addis Ababa, Ethiopia 2024. Methods: A facility-based cross-sectional study was conducted among 422 randomly selected preterm infants who were admitted from Jan 1, 2021- Dec31, 2023. Using a checklist, data were extracted by reviewing charts. The data were then cleaned, coded, and entered into EpiData 4.6, and subsequently exported to SPSS version 27 for analysis. Variables with a p-value of <0.25 on bi-variable analysis were entered into a multi-variable logistic regression analysis. Factors with a p-value of <0.05 were declared statistically significant. Result: A total of 415 neonate charts were reviewed successfully. Although the majority of preterm infants who received Aminophylline for the management of apnea showed improvement, a significant proportion (32.2%) of them did not survive. The odds of death were higher in preterm neonates with: a birthweight of less than 1 kg (AOR = 18.9, 95% CI [4.6, 77.9]), a birthweight between 1 kg and 1.5 kg (AOR = 2.8, 95% CI [1.1, 7.1]), pulmonary hemorrhage (AOR = 3.7, 95% CI [1.2, 11.1]), apnea episodes after the initiation of Aminophylline (AOR = 2.5, 95% CI [1.2, 5.1]), those who did not receive nasal oxygen therapy (AOR = 53.1, 95% CI [24.0, 117.3]), and hypoglycemia (AOR = 3.3, 95% CI [1.5, 7.4], p = 0.003) compared to their respective counterparts. Lastly, premature neonates who were treated with Aminophylline for less than 10 days had 4.8 times higher odds of death compared to those treated for 10 days or more (AOR = 4.8, 95% CI [2.0, 11.4]). Conclusion and recommendation: These findings highlight critical risk factors associated with mortality in preterm infants receiving Aminophylline and underscore the need for targeted interventions to improve survival outcomes. Based on these findings, we recommend implementing enhanced care protocols for extremely/very low birthweight neonates, prioritizing early detection and management of pulmonary hemorrhage, reviewing aminophylline treatment protocols, ensuring universal access to nasal oxygen therapy, optimizing hypoglycemia management protocols, and conducting further research in these areas.